Stock Events

Stock Events

BioVersys 

€25.20
3
-€0.20-0.79%Friday 14:25

Statistics

Day High
25
Day Low
25
52W High
32
52W Low
22.6
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Sep 9Expected
Q2 2025
Q4 2025
Q2 2026
-3.3
-2.86
-2.42
-1.99
Expected EPS
-2.12583264
Actual EPS
-2.8273574112

Financials

-2,723.8%Profit Margin
Unprofitable
2024
2025
859,282.41Revenue
-23.41MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow W33.F. It's not an investment recommendation.
Sandoz Group
2
SDZ.SW

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

BioVersys AG researches and develops antimicrobial drugs for bacterial infections. It develops BV100 that is in Phase 3 clinical trial for carbapenem-resistant Acinetobacter baumannii lung and bloodstream infections. The company is also developing Alpibectir, which is in Phase 2 clinical trial for the treatment of pulmonary and meningeal tuberculosis; BV200 to treat patients with Gram-positive S. aureus; and BV500 for non-tuberculous mycobacteria infections. It has a research and license option agreement with Shionogi & Co., Ltd. to develop ansamycin leads from the BV500 program into clinical candidates. The company was founded in 2008 and is based in Basel, Switzerland.
Show More
CEO
Dr. Marc Gitzinger
Employees
38
Country
Switzerland
ISIN
CH0210362643
WKN
000A410LA

Listings

SW
CH
BIOV.SW
F
DE
W33.F

0 Comments

Share your thoughts

FAQs

What is BioVersys stock price today?▼
The current price of W33.F is €25.20 EUR — it has decreased by -0.79% in the past 24 hours. Watch BioVersys stock price performance more closely on the chart.
What is BioVersys stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange BioVersys stocks are traded under the ticker W33.F.
Is BioVersys stock price growing?▼
W33.F stock has fallen by -2.33% compared to the previous week, the month change is a -6.67% fall, over the last year BioVersys has showed a -3.08% decrease.
When is the next BioVersys earnings date?▼
BioVersys is going to release the next earnings report on March 31, 2027.
What were BioVersys earnings last quarter?▼
W33.F earnings for the last quarter are -2.83 EUR per share, whereas the estimation was -2.13 EUR resulting in a -33% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is BioVersys revenue for the last year?▼
BioVersys revenue for the last year amounts to 859,282.41 EUR.
What is BioVersys net income for the last year?▼
W33.F net income for the last year is -23.41M EUR.
How many employees does BioVersys have?▼
As of November 2, 2026, the company has 38 employees.
In which sector is BioVersys located?▼
BioVersys operates in the Other sector.
When did BioVersys complete a stock split?▼
BioVersys has not had any recent stock splits.
Where is BioVersys headquartered?▼
BioVersys is headquartered in Basel, Switzerland.